Female gender is associated with a better outcome after cardiac resynchronization therapy

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 1, 2011, Pages 82-88

  Leyva, Francisco ^a   Foley, Paul W X ^a   Chalil, Shajil ^a   Irwin, Nick ^b   Smith, Russell E A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

cardiac resynchronization therapy; gender differences; heart failure; mortality

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RHYTHM; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; QRS COMPLEX; SEX DIFFERENCE; SUDDEN DEATH; SURVIVAL; TREATMENT OUTCOME; WALKING; WOMEN'S HEALTH;

EID: 78651331339     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02909.x     Document Type: Article

References (30)

1. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, for the Cardiac Resynchronization-Heart Failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Eng J Med 2005; 352: 1539-1549. (Pubitemid 40517094)
2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass D, De Marco T, Carson P, et al, for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced heart failure. N Eng J Med 2004; 350: 2140-2150.
3. Cazeau S, Leclercq C, Lavergene T, Walker S, Varma C, Linde C, Garrigue S, et al,. Effects of multisite biventricular pacing in patients with heart failure and interventricular conduction delay. N Engl J Med 2001; 344: 873-880.
4. Abraham WT, Fisher WG, Smith AL, Deluergio DB, Leon AR, Kocovic DZ, Packer M, et al,. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853.
5. St. John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, et al,. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003; 107: 1985-1990.
6. Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA Jr, Curtis AB,. Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: Analysis of the MIRACLE study. J Interv Card Electrophysiol 2005; 12: 107-113.
7. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al,. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 2006; 114: 2766-2772.
8. Stabile G, Solimene F, Bertaglia E, La Rocca V, Accogli M, Scaccia A, Marrazzo N, et al,. Long-term outcomes of CRT-PM versus CRT-D recipients. Pacing Clin Electrophysiol 2009; 32 (Suppl. 1): S141-S145.
9. Guyatt GH, Sullivan MJ, Thompson PJ,. The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132: 919-923.
10. Alpert JS, Thygesen K, Antman E, Bassand JP,. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
11. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, Sheppard MN, et al,. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48: 1977-1985.
12. Ritter P, Padeletti L, Gillio-Meina L, Gaggini G,. Determination of the optimal atrioventricular delay in DDD pacing: Comparison between echo and peak endocardial acceleration measurements. Europace 1999; 1: 126-130.
13. Myerburg RJ, Castellanos A,. Cardiac arrest and sudden cardiac death. In:, Braunwald E, (ed.) Heart Disease: A Textbook of Cardiovascular Medicine. New York, WB Saunders Publishing Co, 1997, pp. 742-779.
14. Rockman HA, Juneau C, Chatterjee K, Rouleau JL,. Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1989; 64: 1344-1348.
15. Petrie MC, Dawson NF, Murdoch DR, Davie AP, McMurray JJ,. Failure of women's hearts. Circulation 1999; 99: 2334-2341.
16. Barker W, Mullooly J, Getchell W,. Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994. Circulation 2006; 113: 799-805.
17. Schocken DD, Arrieta MI, Leaverton PE, Ross EA,. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301-306.
18. Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV,. Prognosis and determinants of survival in patients newly hospitalized for heart failure: A population-based study. Arch Intern Med 2002; 162: 1689-1694.
19. Aurigemma G, Gaasch W,. Gender differences in older patients with pressure-overload hypertrophy of the left ventricle. Cardiology 1995; 86: 310-317.
20. Carroll EP, EP C, Feldman T, Ward D, Lang R, McGaughey D, Karp R,. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992; 86: 1099-1107.
21. Douglas P, Katz S, Weinberg E, Chen M, Bishop S, Lorell B,. Hypertrophic remodeling: Gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol 1998; 32: 1118-1125.
22. Tamura T, Said S, Gerdes A,. Gender-related differences in myocyte remodeling in progression to heart failure. Hypertension 1999; 33: 676-680.
23. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, et al,. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.
24. Lilli A, Ricciardi G, Porciani MC, Perini AP, Pieragnoli P, Musilli N, Colella A, et al,. Cardiac resynchronization therapy: Gender related differences in left ventricular reverse remodeling. Pacing Clin Electrophysiol 2007; 30: 1349-1355.
25. Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, Young JB, et al,. Gender differences in advanced heart failure: Insights from the BEST study. J Am Coll Cardiol 2003; 42: 2128-2134.
26. The Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001; 344: 1659-1667.
27. Hamdan MH, Zagrodzky JD, Joglar JA, Sheehan CJ, Ramaswamy K, Erdner JF, Page RL, et al,. Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction. Circulation 2000; 102: 1027-1032.
28. Grassi G, Vincenti A, Brambilla R, Trevano FQ, Dell'Oro R, Ciro A, Trocino G, et al,. Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure. Hypertension 2004; 44: 727-731.
29. Najem B, Unger P, Preumont N, Jansens JL, Houssiere A, Pathak A, Xhaet O, et al,. Sympathetic control after cardiac resynchronization therapy: Responders versus nonresponders. Am J Physiol Heart Circ Physiol 2006; 291: H2647-H2652.
30. Alaeddini J, Wood MA, Amin MS, Ellenbogen KA,. Gender disparity in the use of cardiac resynchronization therapy in the United States. Pacing Clin Electrophysiol 2008; 31: 468-472.